We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

7532:TSEPan Pacific International Holdings Corporation Analysis

Data as of 2026-06-22 - not real-time

¥810.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Pan Pacific International Holdings is trading at ¥810, well below its 20‑day (¥835.7), 50‑day (¥880.4) and 200‑day (¥950.1) moving averages, signaling a bearish technical backdrop. However, the RSI of 36.99 suggests the stock is approaching oversold territory, and the MACD histogram has turned positive, indicating a potential short‑term rebound toward the immediate resistance at ¥907.4. Volatility remains elevated at 34% over the past 30 days, and trading volume is on a downtrend, which adds uncertainty to price moves. On the fundamentals side, revenue grew 10.2% YoY and forward earnings are projected to surge, reflected in a forward P/E of 4.57 versus a trailing P/E of 24.24. The company carries a high debt‑to‑equity ratio of 55.8 and a negative beta of –0.36, underscoring both leverage risk and defensive market behavior. Despite these concerns, the dividend yield of 1.04% with a 24.5% payout ratio appears sustainable given the strong cash flow generation. A discounted cash flow model values the shares at roughly ¥445, implying the current price is significantly above intrinsic estimates, yet analyst consensus targets around ¥1,100, driven by expectations of earnings acceleration. The market sentiment is extremely bullish (Fear & Greed Index 91.46), which may be inflating price expectations. Balancing the technical weakness, high leverage, and optimistic earnings outlook suggests a nuanced outlook: potential upside if earnings materialize, but downside risk if debt pressures persist. Investors should weigh the short‑term bounce potential against longer‑term valuation concerns.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • RSI near oversold levels
  • Bullish MACD histogram
  • Support zone around ¥795

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward earnings surge (forward EPS ¥177.19)
  • Forward P/E of 4.57 indicating cheap valuation
  • Analyst target price near ¥1,100

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • High debt‑to‑equity ratio (55.8)
  • DCF fair value well below current price
  • Defensive consumer sector providing stability

Key Metrics & Analysis

Financial Health

Revenue Growth10.20%
P/E Ratio24.2
Debt/Equity55.75
P/B Ratio3.5
Op. Cash Flow¥154.9B
Free Cash Flow¥76.5B

Technical Analysis

TrendBearish
RSI37.0
Support¥794.70
Resistance¥907.40
MA 20¥835.71
MA 50¥880.42
MA 200¥950.09
MACDBullish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

Fair Value¥444.74
Target Price¥1,095.79
Upside/Downside35.28%
GradeOvervalued
TypeGrowth
Dividend Yield1.04%

Risk Assessment

Beta-0.36
Volatility34.37%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.